Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy
Clinical trial NCT02979548 · UNKNOWN
Trial details
- NCT number
- NCT02979548
- Sponsor
- Dr Atul Sharma
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-06-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.